Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Painting away fatigue: art therapy trial for blood cancer patients

NCT ID NCT07551817

First seen Apr 30, 2026 · Last updated Jun 20, 2026 · Updated 9 times

Summary

This study tests whether doing art activities (like drawing or painting) can reduce fatigue, anxiety, and improve quality of life in adults with blood cancers. Fifty-two patients will be split into two groups: one gets six art sessions over two weeks, the other gets standard care. Researchers will measure changes using questionnaires about fatigue, anxiety, depression, and how present the nurse feels.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Gazi University

    Ankara, Çankaya, 06560, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

art-based intervention (drawing, painting, or similar creative activities)

What this could lead to

If it works, this could offer a simple, drug-free way to help blood cancer patients feel less tired and anxious during treatment.

What could go wrong

This is a small, early-stage study (52 people) testing a non-medical intervention. Results may not apply broadly, and the effect on fatigue or anxiety may be minimal.

Conditions

The condition(s) this trial relates to.

anxiety disorder Fatigue hematopoietic and lymphoid system neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.